Barbara Ann Karmanos Cancer Institute — Detroit, Michigan

Barbara Ann Karmanos Cancer Institute is a clinical research site located in Detroit, Michigan, United States 48201-1379.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Barbara Ann Karmanos Cancer Institute has participated in 583 clinical trials with 55 currently active.

Therapeutic areas: Pancreatic Cancer, Breast Cancer, Ovarian Cancer.

Sponsors: SWOG Cancer Research Network, NSABP Foundation Inc, Barbara Ann Karmanos Cancer Institute.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Barbara Ann Karmanos Cancer Institute?

Barbara Ann Karmanos Cancer Institute has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Barbara Ann Karmanos Cancer Institute conducted?

Barbara Ann Karmanos Cancer Institute has 583 clinical trials on record, with 55 currently active. Their work covers Pancreatic Cancer, Breast Cancer, Ovarian Cancer.

Is Barbara Ann Karmanos Cancer Institute accredited by Crixeo Health?

Barbara Ann Karmanos Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Barbara Ann Karmanos Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.